Protara Therapeutics (TARA) Exchange Rate Effect (2015 - 2018)
Protara Therapeutics (TARA) posted quarterly Exchange Rate Effect of -$2000.0 for Q4 2018, down 100.53% year-over-year from $376000.0 in Q4 2017, and up 98.23% quarter-over-quarter from -$113000.0 in Q2 2018.
Powered by 
Analysis
Protara Therapeutics (TARA) Exchange Rate Effect (2015 - 2018) Analysis & Trends
Protara Therapeutics (TARA) has reported Exchange Rate Effect for 4 consecutive years, with -$2000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Exchange Rate Effect fell 100.53% year-over-year to -$2000.0; the TTM figure through Dec 2018 stood at $22000.0 (down 87.78% YoY), while the FY2018 annual figure was $22000.0, down 87.78% from the prior year.
- Exchange Rate Effect grew to -$2000.0 in Q4 2018 per TARA's latest filing, from -$113000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $376000.0 in Q4 2017 and bottomed at -$338000.0 in Q2 2017.
- Historically, Exchange Rate Effect has averaged $4384.6 across 4 years, with a median of -$2000.0 in 2018.
- On a YoY basis, Exchange Rate Effect climbed as much as 558.54% in 2017 and fell as far as 589.8% in 2017.
- Protara Therapeutics' Exchange Rate Effect stood at -$46000.0 in 2015, then sank by 78.26% to -$82000.0 in 2016, then surged by 558.54% to $376000.0 in 2017, then slumped by 100.53% to -$2000.0 in 2018.
- Business Quant data shows TARA's Exchange Rate Effect at -$2000.0 in Q4 2018, -$113000.0 in Q2 2018, and $137000.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -2,000.00 |
| Jun 30, 2018 | -113,000.00 |
| Mar 31, 2018 | 137,000.00 |
| Dec 31, 2017 | 376,000.00 |
| Sep 30, 2017 | 83,000.00 |
| Jun 30, 2017 | -338,000.00 |
| Mar 31, 2017 | 59,000.00 |
| Dec 31, 2016 | -82,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Jun 30, 2016 | -49,000.00 |
| Mar 31, 2016 | 28,000.00 |
| Dec 31, 2015 | -46,000.00 |
| Sep 30, 2015 | -23,000.00 |